Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

Pamela S. Douglas; Allen Taylor; Diane Bild; Robert Bonow; Philip Greenland; Michael Lauer; Frank Peacock; James Udelson

doi:10.1016/j.echo.2009.05.026

Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

Pamela S. Douglas^*, Allen Taylor, Diane Bild, Robert Bonow, Philip Greenland, Michael Lauer, Frank Peacock, James Udelson

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.

Original language	English (US)
Pages (from-to)	766-773
Number of pages	8
Journal	Journal of the American Society of Echocardiography
Volume	22
Issue number	7
DOIs	https://doi.org/10.1016/j.echo.2009.05.026
State	Published - Jul 2009

Funding

Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicine's Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and the Medicine's Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging.

Keywords

Cardiovascular imaging
Chest pain diagnosis
Clinical trials

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.echo.2009.05.026

Cite this

@article{67e9b59a7d704972a779e84896e758ab,

title = "Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute",

abstract = "In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.",

keywords = "Cardiovascular imaging, Chest pain diagnosis, Clinical trials",

author = "Douglas, {Pamela S.} and Allen Taylor and Diane Bild and Robert Bonow and Philip Greenland and Michael Lauer and Frank Peacock and James Udelson",

note = "Funding Information: Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicine's Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and the Medicine's Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging. ",

year = "2009",

month = jul,

doi = "10.1016/j.echo.2009.05.026",

language = "English (US)",

volume = "22",

pages = "766--773",

journal = "Journal of the American Society of Echocardiography",

issn = "0894-7317",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Outcomes Research in Cardiovascular Imaging

T2 - Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

AU - Douglas, Pamela S.

AU - Taylor, Allen

AU - Bild, Diane

AU - Bonow, Robert

AU - Greenland, Philip

AU - Lauer, Michael

AU - Peacock, Frank

AU - Udelson, James

N1 - Funding Information: Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicine's Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and the Medicine's Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging.

PY - 2009/7

Y1 - 2009/7

N2 - In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.

AB - In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.

KW - Cardiovascular imaging

KW - Chest pain diagnosis

KW - Clinical trials

UR - http://www.scopus.com/inward/record.url?scp=67649089040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649089040&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2009.05.026

DO - 10.1016/j.echo.2009.05.026

M3 - Article

C2 - 19560655

AN - SCOPUS:67649089040

SN - 0894-7317

VL - 22

SP - 766

EP - 773

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

IS - 7

ER -

Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this